News | Cardiac Imaging | May 02, 2025

New feature provides AI-enhanced 3D imaging to improve neurovascular visualization and streamline workflows.

Viz 3D CTA Delivers Enhanced Imaging, Accelerates Clinical Decision-Making

April 30, 2025 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has launched Viz 3D CTA, a new solution that automatically converts computed tomography angiography (CTA) scans into high-resolution, AI-enhanced 3D images for faster and clearer neurovascular visualization.

Fully integrated into the Viz.ai platform, this capability enables care teams to interact with complex neurovascular anatomy in real-time — automatically removing bone and venous structures to enhance clarity and support time savings in stroke and aneurysm workflows.

“Viz 3D CTA gives me a clearer, faster view of what’s going on. Being able to rotate the image and see vessels from different angles makes a big difference, especially in tricky areas,” said Benjamin Alwood, MD, neurologist at UF Health Jacksonville. “It’s also a great safety net for spotting occlusions that might otherwise be missed. Having this kind of clarity right away helps me make quicker, more confident decisions.”

Viz 3D CTA addresses challenges in neurovascular imaging, including delays due to manual 3D renderings, limited spatial context in PACS, and difficulty viewing smaller or more distal vessel abnormalities. With automated post-processing, skull-stripped views, and interactive tools —including sagittal and axial rotation—Viz 3D CTA offers clinicians a dynamic, full-brain perspective within minutes.

“With Viz 3D CTA, we’re extending the Viz.ai One® platform with a powerful imaging tool that enables clearer, faster decisions in neurovascular care,” said Prem Batchu-Green, VP of Care Pathways, Value and Success at Viz.ai. “We are proud to bring this capability directly into the hands of providers who are working to save lives and preserve function every day.”

Viz 3D CTA is now available to hospitals and health systems on the Viz.ai One platform, which is deployed in over 1,700 hospitals and health systems. To learn more about Viz 3D CTA, visit viz.ai/neuro.


Related Content

Feature | Cardiac Imaging | Kyle Hardner

Advances in coronary CT angiography (CCTA) have reached the point where image quality and AI capabilities are creating ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | Interventional Radiology

Feb. 2, 2026 — GE HealthCare has announced that Allia Moveo has received U.S. Food and Drug Administration (FDA) 510(k) ...

Time February 02, 2026
arrow
News | Radiology Imaging

Jan.26, 2026 — SimonMed Imaging has unveiled an updated brand and the launch of SimonMed Longevity, a new division ...

Time January 27, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 22, 2026 — Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal ...

Time January 23, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
Subscribe Now